Stämm Biotech
Manuela Alanis has a diverse work experience which began in 2017 as an Intern at Victhor Implantes. In 2018, they were the Quality Department Supervisor at Victhor Implantes, where they were responsible for maintaining and updating the company's quality system. Manuela also cofounded detecTEA, a venture centered in the design and development of a screening device for the autistic spectrum disorder through pupillary reaction measurements. In the same year, they worked as a Therapeutic Assistant. From 2020 to present, Manuela has been employed at Caspr Biotech as a Scientist and Biomedical Engineer, where they focus on the design and execution of experiments. Currently, they are a Product Leader and Microfluidic Engineer at Stämm Biotech.
Manuela Alanis completed their Ingeniería degree in Bioingeniería e ingeniería biomédica from Instituto Tecnológico de Buenos Aires between 2012 and 2018. Manuela also participated in an Intercambio program at Politecnico di Milano between 2016 and 2017. In addition, they have obtained various certifications, including a Diplomatura en Diseño e Impresión 3D from UTN - Facultad Regional Córdoba in December 2021, Fundamentos de PCR en tiempo real y operación de la plataforma Quantum Studio 5 Real-Time PCR System from Thermo Fisher Scientific in October 2021, Auditor interno 13485: 2016 from TÜV NORD Argentina in May 2021, Python for Data Science and Machine Learning Bootcamp from Udemy in July 2020, Design and Interpretation of Clinical Trials from Coursera in May 2020, and a Curso Online sobre Paradigmas, Pesquisa, Diagnóstico e Intervención Temprana en CEA from PANAACEA in July 2019.
This person is not in any offices
Stämm Biotech
Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, and repeatable. We have developed the first methodology for continuous industrial production of biologics and cell therapies leveraging microfluidics and 3D printing. In 2020, the total volume of anthropogenic mass matched the total amount of biomass globally, which means it matched everything that is alive on the planet. We can only expect that this number keeps increasing since it's key to solving humanity's systemic challenges. But we have to make sure that conquering the great challenges of humanity doesn’t extinguish the planet’s capacity to sustain life. The current way of biomanufacturing has provided humanity with innumerable solutions. Bioprocessing is the most efficient way to align human advancement with a thriving nature. In order to prevent nature from perishing, we aim to put it at the center of all human activities by incorporating its knowledge system within the process of achieving humanity's prosperity. Founded in 2016, Stämm mimics nature’s use of laminar flow to down-size a whole biotech facility into an all-in-one, plug & play desktop unit. Our focus is to decentralize bioprocesses and democratize access to biotechnology products, thus freeing our partners to focus on the disruptive discoveries that make an impact on people’s life.